Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures.
about
Exposure to MIV-150 from a high-dose intravaginal ring results in limited emergence of drug resistance mutations in SHIV-RT infected rhesus macaquesA single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity.Resistance to N-peptide fusion inhibitors correlates with thermodynamic stability of the gp41 six-helix bundle but not HIV entry kinetics.Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors.Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.
P2860
Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Vicriviroc resistance decay an ...... tial drug selection pressures.
@ast
Vicriviroc resistance decay an ...... tial drug selection pressures.
@en
type
label
Vicriviroc resistance decay an ...... tial drug selection pressures.
@ast
Vicriviroc resistance decay an ...... tial drug selection pressures.
@en
prefLabel
Vicriviroc resistance decay an ...... tial drug selection pressures.
@ast
Vicriviroc resistance decay an ...... tial drug selection pressures.
@en
P2093
P2860
P356
P1433
P1476
Vicriviroc resistance decay an ...... tial drug selection pressures.
@en
P2093
Allison L Schure
Athe M N Tsibris
Daniel R Kuritzkes
Eoin Coakley
Kay E Leopold
Natalie Mazur
Opass Putcharoen
Roger Paredes
Roy M Gulick
Zhaohui Su
P2860
P304
P356
10.1128/JVI.00286-12
P407
P577
2012-04-04T00:00:00Z